Monsanto Roundup Lawsuit

Wednesday, July 21, 2010

THE GLAXO/MHRA/PAXIL FILES

SPECIAL THANKS TO DOUG BREMNER, CHRISTOPHER LANE AND HEALTHY SKEPTICISM FOR MAKING SOME OF THESE DOCUMENTS AVAILABLE






PAXIL/SEROXAT - GREATEST NUMBER OF SUICIDE ATTEMPTS


----


GSK PAXIL CASPPER DOCUMENT


----


GLAXOSMITHKLINE PROGRAM CALLED “PSYCHNET”


----


FOREWORD BY PAUL N. JENNER, DIRECTOR AND VICE PRESIDENT OF NEUROSCIENCE AND STRATEGIC PRODUCT DEVELOPMENT


----


SECTION 1: TOWARDS THE SECTION BILLION -- ALL SSRI'S ARE NOT THE SAME


----


SECTION 2: NEW INDICATIONS: SOCIAL ANXIETY DISORDER / SOCIAL PHOBIA


----


SECTION 3: ISSUES MANAGEMENT: MANAGING THE DISCONTINUATION ISSUE

----

"DURATION OF TREATMENT AND DEPRESSION: RELAPSE AND RECURRENCE RATES"

----

"PAXIL CR" PRODUCT MONOGRAPH


----


PAXIL LITIGATION DOCUMENTS


----


GSK's PAXIL.COM...STILL A WEALTH OF [DIS] INFORMATION


----


DOCUMENT RETENTION, LETTERS TO MINISTERS, LETTERS AND EMAILS ABOUT SEROXAT AND LIST OF FOI REQUESTS


----


MINUTES OF MEETING BETWEEN MHRA AND BOB FIDDAMAN


----


PRESS RELEASE: GSK INVESTIGATION CONCLUDES


----


MHRA INVESTIGATION INTO GLAXOSMITHKLINE/SEROXAT


----


GSK SEROXAT - LETTER TO GSK FROM MHRA


----


GSK SEROXAT - LETTER TO TRADE ASSOCIATIONS


----


SUMMARY OF REGULATORY ACTION


----


LETTER FROM GSK CHIEF MEDICAL OFFICER TO MHRA


----


MHRA RESPONSE TO LETTER FROM GSK CHIEF MEDICAL OFFICER


----


PAXIL STUDY 329 ALL OVER AGAIN?
Article By Bob Fiddaman



----


MARKET SENTINEL'S STAKEHOLDER ANALYSIS COMMISSIONED BY THE UK MHRA TO ASSESS PUBLIC DISCUSSION OF THE SEROXAT CONTROVERSY


----


KILKER V GLAXOSMITHKLINE COURT TRANSCRIPTS

----

PAXIL STUDY 329: PAROXETINE vs IMIPRAMINE vs PLACEBO IN ADOLESCENTS



Fid

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING